Bronchial reactivity to inhaled hypertonic saline solutions in children with cystic fibrosis
Background. Inhaled hypertonic saline solutions (IHSS) are included in the list of mandatory prescriptions in the treatment of cystic fibrosis (CF). However, some patients with CF may develop bronchial hyperreactivity (BHR), which may be the cause of violation of the treatment protocol. The purpose...
Main Authors: | S.I. Ilchenko, A.O. Fialkovska, K.V. Skriabinа, S.G. Ivanus |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaslavsky O.Yu.
2022-09-01
|
Series: | Zdorovʹe Rebenka |
Subjects: | |
Online Access: | https://childshealth.zaslavsky.com.ua/index.php/journal/article/view/1523 |
Similar Items
-
Predicting the tolerability of inhalation therapy as a stage of a personalized approach in the treatment of children with cystic fibrosis
by: K.V. Skriabinа, et al.
Published: (2023-04-01) -
Protective effect of bronchial challenge with hypertonic saline on nocturnal asthma
by: M.C. Borges, et al.
Published: (2008-03-01) -
Hypertonic saline in the treatment of patients with cystic fibrosis in Russian Federation
by: E. I. Kondatyeva, et al.
Published: (2021-10-01) -
Efficacy of hypertonic saline versus isotonic saline among children with cystic fibrosis: A systematic review and meta-analysis
by: Saad Ehsan Ullah, et al.
Published: (2023-01-01) -
Experience of inhaled hypertonic saline use in pediatric pulmonology
by: Yu. L. Mizernitskiy, et al.
Published: (2022-07-01)